Safety, tolerability, pharmacokinetic, pharmacodynamic and immunogenicity profiles of Exendin-4-IgG4-Fc in healthy subjects: A phase 1, single-centre, randomized, double-blind, dose escalation study
- 浏览0

Diabetes, obesity & metabolism.
1395-1406页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文